Related Experiment Video
Updated: Dec 24, 2025

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Occurrence of Blastocystis in Patients with Clostridioides difficile Infection
Laura Vega1, Giovanny Herrera1, Marina Muñoz1
1Grupo de Investigaciones Microbiológicas de la Universidad del Rosario (GIMUR), Departamento de Biología, Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá 110221, Colombia.
Abstract:
Clostridiodes difficile comprises a public-health threat that has been understudied in Colombia. Hypervirulent strains of C. difficile harbor multiple toxins, can be easily spread, and can have their onset of disease within healthcare facilities (HCFO) and the community (CO). Studies have shown that a disrupted microbiota (e.g., dysbiosis) may allow C. difficile infection (CDI). It has been suggested that dysbiosis prevents colonization by the anaerobic eukaryote Blastocystis, possibly due to an increase in luminal oxygen tension. No study has found co-occurrence of CDI and Blastocystis. Therefore, we aimed to determine the frequencies of C. difficile and Blastocystis infection/colonization in 220 diarrheal fecal samples. Molecular detection by PCR for both microorganisms was performed, with descriptive analyses of four variables (CDI detection, determination of C. difficile toxigenic profiles, Blastocystis detection, and patient site of onset). We demonstrate a significant association between the presence of Blastocystis and CDI, with coinfection found in 61 patients, and show a high frequency of CDI among both HCFO and CO groups. Our results of coinfection frequencies could support hypotheses that suggest Blastocystis can adapt to dysbiosis and oxidative stress. Further, the presence of toxigenic C. difficile occurring outside healthcare facilities shown here raises the alarm for community wide spread.
Insights
This study found a significant association between Blastocystis and Clostridioides difficile infection (CDI) in Colombia. Coinfection was observed in 61 patients, highlighting the spread of C. difficile in both healthcare and community settings.
Area of Science:
- Microbiology
- Infectious Diseases
- Public Health
Background:
- Clostridioides difficile is a significant public health threat, particularly hypervirulent strains causing healthcare-associated (HCFO) and community-onset (CO) infections.
- Gut microbiota disruption (dysbiosis) is linked to C. difficile infection (CDI) susceptibility.
- Previous research suggested dysbiosis might inhibit Blastocystis colonization due to increased oxygen, with no prior studies reporting CDI and Blastocystis co-occurrence.
Purpose of the Study:
- To determine the frequencies of C. difficile and Blastocystis infection/colonization in diarrheal fecal samples in Colombia.
- To investigate the association between C. difficile and Blastocystis in a Colombian cohort.
- To analyze the toxigenic profiles and patient site of onset for C. difficile.
Main Methods:
- Molecular detection using PCR was performed on 220 diarrheal fecal samples.
- Descriptive analyses were conducted for CDI detection, C. difficile toxigenic profiles, Blastocystis detection, and patient site of onset.
- The study focused on identifying co-occurrence and associations between the two microorganisms.
Main Results:
- A significant association was found between the presence of Blastocystis and CDI.
- Coinfection with C. difficile and Blastocystis was identified in 61 patients.
- High frequencies of CDI were observed in both HCFO and CO patient groups.
Conclusions:
- The coinfection frequencies support hypotheses that Blastocystis can adapt to dysbiosis and oxidative stress.
- The study highlights a concerning frequency of toxigenic C. difficile in community settings, indicating potential for widespread community transmission.
- Further research is warranted to understand the complex interplay between C. difficile, Blastocystis, and the gut microbiome.
More Related Videos
09:12A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
06:51Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Related Concept Videos
Fungal Phylum Microsporidia
Diversity of Protists II